| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/12/2006 | US7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/12/2006 | US7105518 Thiopyrane-4-ones as DNA protein kinase inhibitors |
| 09/12/2006 | US7105516 Compounds for the treatment of premature ejaculation |
| 09/12/2006 | US7105515 Such as N-[3-(2-diethylaminoethyl)-1H-indol-5-yl]-5-chloro-3-methylbenzo[b]thiophene-2-sulphonamide for treating anxiety, depression, cognitive memory disorders and senile dementia, psychosis, infant hyperkinesia (ADHD, attention deficit/hyperactivity disorder) |
| 09/12/2006 | US7105514 2-methyl-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic; acidinhibit aldose reductase; treating diabetes mellitus, including, diabetic cataracts, retinopathy, nephropathy, and neuropathy |
| 09/12/2006 | US7105513 Cardiovascular disorders; strokes; hypotensive agents |
| 09/12/2006 | US7105512 Having anti- inflammatory effect, which is less irritant, which has high safety and storage stability |
| 09/12/2006 | US7105511 Fluorescent fused-ring triazoles that inhibit cell proliferation and uses thereof |
| 09/12/2006 | US7105510 dipyrido [1,4] diazepine derivatives; treating and preventing hiv |
| 09/12/2006 | US7105509 Benzodiazepine derivatives as APP modulators |
| 09/12/2006 | US7105508 Integrin receptors antagonists |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/12/2006 | US7105506 For therapy of cardiovascular disorders and erectile dysfunction |
| 09/12/2006 | US7105505 Benzimidazole derivatives useful as histamine H3 antagonists |
| 09/12/2006 | US7105504 Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease |
| 09/12/2006 | US7105503 Pyrazole compounds |
| 09/12/2006 | US7105502 Releasing nitric oxide; controlling blood pressure; cytotoxic compound |
| 09/12/2006 | US7105501 Compositions with vascular damaging activity |
| 09/12/2006 | US7105500 Covalently fixing antimicrobials complexed with fiber-reactive cyclodextrin derivatives to cotton, synthetic polyamide or cellulosic fibers; controlled delivery, reactive cyclodextrin acts as both an anchor to the fiber materials and as a carrier for antimicrobial; washing durability |
| 09/12/2006 | US7105499 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 09/12/2006 | US7105498 Increases bioavailability of uridine and cytidine; treating hepatopathies, diabetes, heart disease, cerebrovascular disorders, Parkinson's disease; dosage forms |
| 09/12/2006 | US7105497 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders |
| 09/12/2006 | US7105493 Methods and compositions for treating flaviviruses and pestiviruses |
| 09/12/2006 | US7105492 Antitumor agents |
| 09/12/2006 | US7105491 Biosynthesis of enediyne compounds by manipulation of C-1027 gene pathway |
| 09/12/2006 | US7105490 Methods and compositions for treating polycystic ovary syndrome |
| 09/12/2006 | US7105489 Methods and compositions for treating polycystic ovary syndrome |
| 09/12/2006 | US7105486 Administering L-lysine-d-amphetamine; attention deficit hyperactivity disorder; decreasing the bioavailability of amphetamine by intravenous or intranasal administration, further limiting their abuse liability. |
| 09/12/2006 | US7105484 GDNF receptorα |
| 09/12/2006 | US7105483 Phosphinic pseudopeptide derivatives for the selective inhibition of the C-terminal active site of angiotensin I converting enzyme (ACE) |
| 09/12/2006 | US7105482 Administering {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester; parasitic infections, thymoma, and lymphoid malignancies; prevents the metabolic degradation of the angiogenesis inhibitor |
| 09/12/2006 | US7105473 Multi-purpose solutions for contact lens; aqueous liquid medium of an antimicrobial component and hexamethylene biguanide polymer; increased biocidal efficacy, minimal corneal epithelial punctate fluorescein staining |
| 09/12/2006 | US7105333 Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon |
| 09/12/2006 | US7105324 Nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use |
| 09/12/2006 | US7105317 Immunogenic compositions comprising vrg-gene products from Bordetella extracts |
| 09/12/2006 | US7105229 Dispersing a matrix of nanostructured liquid phase or a dehydrated variant and a nanostructured liquid crystalline phase or a dehydrated variant in nonlamellar material; cooling or evaporating a volatile solvent |
| 09/12/2006 | US7105188 Fermentation solution of a sugar component, water, and a pine leaf cluster; allowing fermentation solution to stand for a period of time; treating atopic dermatitis and athlete's foot |
| 09/12/2006 | US7105186 Triterpene compositions and methods for use thereof |
| 09/12/2006 | US7105185 Solvent extraction from plant using liquid carbon dioxide; therapy for muscular disorders |
| 09/12/2006 | US7105180 Storage stability; bioavailability; core containing drug such as omeprazole, enteric overcoating |
| 09/12/2006 | US7105179 Crystal forms of azithromycin |
| 09/12/2006 | US7105178 Cardiotonic composition |
| 09/12/2006 | US7105176 Dissolving or dispersing active compounds in aqueous or colloidal dispersion of a proteinaceous protecting colloid, flocculating with active compound out of dispersion separating off flocculated solid; forming dry powder |
| 09/12/2006 | US7105172 Treatment of rosacea |
| 09/12/2006 | US7105162 Peptide or protein from a pathogenic or tumor agent having immunomodulatory activity with an adjuvant capable of increasing the binding of the peptide to the cells of the individual or increasing the entry of the peptide into the cells; strengthening immunomodulatory activity; polyamino acids adjuvants |
| 09/12/2006 | US7105157 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 09/12/2006 | US7105050 Method for the production of low defect density silicon |
| 09/12/2006 | CA2406680C Topical anti-acne composition |
| 09/12/2006 | CA2385006C Reduction of hair growth |
| 09/12/2006 | CA2366705C Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields |
| 09/12/2006 | CA2346539C Compositions and methods for enhancing receptor-mediated cellular internalization |
| 09/12/2006 | CA2315110C Pellets having a core coated with an antifungal and a polymer |
| 09/12/2006 | CA2312545C Solid, thermoformable, controlled-release pharmaceutical compound |
| 09/12/2006 | CA2307037C Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 09/12/2006 | CA2251060C Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action |
| 09/12/2006 | CA2241788C Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them |
| 09/12/2006 | CA2240684C Aerosol preparation |
| 09/12/2006 | CA2235986C Inhibitors of protein isoprenyl transferases |
| 09/12/2006 | CA2215069C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 09/12/2006 | CA2194576C Long-acting oxytetracycline composition |
| 09/12/2006 | CA2180730C Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
| 09/12/2006 | CA2167004C Agent for treating mental disorders associated with cerebrovascular disorders |
| 09/12/2006 | CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 09/12/2006 | CA2120531C Dermatologic and/or cosmetic composition containing retinoidic compounds |
| 09/11/2006 | CA2500676A1 Preparation of acid addition salts of amine bases by solid phase-gas phase reactions |
| 09/09/2006 | WO2007144686A1 Nucleosides with non-natural bases as anti-viral agents |
| 09/09/2006 | CA2600359A1 Nucleosides with non-natural bases as anti-viral agents |
| 09/08/2006 | WO2006094248A1 Aryl-substituted cyclic sirtuin modulators |
| 09/08/2006 | WO2006094246A2 N-arylmethyl benzamide sirtuin modulators |
| 09/08/2006 | WO2006094236A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | WO2006094235A1 Fused heterocyclic compounds and their use as sirtuin modulators |
| 09/08/2006 | WO2006094233A1 N,n'-dicyclic isothiourea sirtuin modulators |
| 09/08/2006 | WO2006094063A1 Quinolinone compounds as 5-ht4 receptor agonists |
| 09/08/2006 | WO2006094034A1 Cinnoline compounds and their use as liver x receptor modilators |
| 09/08/2006 | WO2006094028A1 Combinaion therapy for topical application in the treatment of dry eye syndrome |
| 09/08/2006 | WO2006094026A1 Pharmaceutically acceptable carrier for ophthalmic compositions |
| 09/08/2006 | WO2006094003A1 Novel cathepsin c inhibitors and their use |
| 09/08/2006 | WO2006093994A2 Methods and compositions for increasing the safety and efficacy of albumin-binding drugs |
| 09/08/2006 | WO2006093993A1 Novel c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity |
| 09/08/2006 | WO2006093991A1 Compounds which bind psma and uses thereof |
| 09/08/2006 | WO2006093987A1 Tricyclic-nucleoside compounds for treating viral infections |
| 09/08/2006 | WO2006093986A1 Tricyclic-nucleoside prodrugs for treating viral infections |
| 09/08/2006 | WO2006093864A1 Cardiovascular compounds comprising nitric oxide enhancing groups, compositions and methods of use |
| 09/08/2006 | WO2006093853A1 Crystalline and amorphous 4-cyano-n{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride |
| 09/08/2006 | WO2006093823A1 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 09/08/2006 | WO2006093813A2 Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer |
| 09/08/2006 | WO2006093801A1 Thiadiazine derivatives useful as anti-infective agents |
| 09/08/2006 | WO2006093784A2 Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents |
| 09/08/2006 | WO2006093774A2 Method of treatment of diarrhea-predominant ibs in a female subject receiving contraceptive therapy |
| 09/08/2006 | WO2006093745A1 Purification of rapamycin |
| 09/08/2006 | WO2006093719A1 An efficient and stereoselective process for large scale synthesis of 3-(r)-3- (2,3-dihydrobenzofuran-5-yl)-1,2,3,4- tetrahydropyrrolo{3,4-b}quinolin-9-one |
| 09/08/2006 | WO2006093677A1 Tetracyclic sulfonamide compounds and methods of use thereof |
| 09/08/2006 | WO2006093667A1 Tetracyclic amino and carboxamido compounds and methods of use thereof |
| 09/08/2006 | WO2006093514A2 Aryl and arylalkylenyl substituted thiazoloquinolines and thiazolonaphthyridines |
| 09/08/2006 | WO2006093502A1 Process for preparation of probucol derivatives |
| 09/08/2006 | WO2006093501A1 Process for preparation of probucol derivatives |
| 09/08/2006 | WO2006093493A1 Room temperature stable aqueous liquid pharmaceutical composition |
| 09/08/2006 | WO2006093401A2 Liquid non-flammable gas mixture and a container and package therefor |
| 09/08/2006 | WO2006093354A1 Production intermediate of (s)-2-[3-(n-{[4-(4-fluorophenoxy)phenyl]methyl}carbamoyl)-4-methoxyphenylmethyl]butanoic acid |
| 09/08/2006 | WO2006093353A1 Release-control composition |